Skip to main content
logo
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
16.82
-0.27 (-1.58%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Obsidian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Last Close Price
16.826.2713.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Debt / Equity Ratio
0.100.060.04
Net Debt / Equity Ratio
-1.04-1.06-0.99
Net Debt / EBITDA Ratio
0.330.731.80
Net Debt / FCF Ratio
0.340.842.13
Quick Ratio
1.715.2410.46
Current Ratio
2.305.3110.75
Return on Equity (ROE)
--85.41%-
Return on Assets (ROA)
--48.51%-
Return on Capital Employed (ROCE)
-311.20%-144.30%-54.40%
SEC Filings: 10-K · 10-Q